Search | Médecins Sans Frontières Access Campaign

19 results found

Thousands of demonstrators took to the streets in Delhi once again on 2 March, 2011, in protest over the planned Free Trade Agreement between India and the European Union (EU) which will restrict access to life-saving medicines.

Press release |

14 February 2024

Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is

Leaked text shows India-EFTA trade deal includes excessive intellectual property provisions that may require India to gut pro-public health national laws, which may undermine people's access to affordable medicines from India

Tags Intellectual property and trade European Free Trade Association India

Technical brief |

15 November 2023

Access to TB Testing and Treatments: GeneXpert and Delamanid

The access barriers on lifesaving TB tools

Tags Tuberculosis drug-resistant TBtuberculosis GeneXpert CepheidOtsuka

A pharmacist unpacks medications at the mobile clinic pharmacy. Through mobile clinics, MSF provides medical services to local populations.

Press release |

14 March 2023

News Update: EU-India FTA negotiations could have negative impact on access to medicines

MSF response to negotiations on an India-EU free trade agreement (FTA) regarding harmful intellectual property (IP) provisions

Tags Intellectual property and trade free trade agreement European CommissionEuropean Free Trade Association United KingdomIndiaEuropean Union

MSF Nurse taking vitals of nine years old XDRTB + EPTB male child at MSF independent Clinic, Mumbai- India

Press release |

20 April 2021

MSF supports TB survivors’ court case for Indian government to override patents on lifesaving TB drugs

Next week the Indian government is expected to decide whether it is willing to override patents on two critical tuberculosis (TB) drugs following a court petition filed at the Mumbai High Court by two survivors of TB and activists. MSF ...

Tags Tuberculosis drug-resistant TB bedaquilinedelamanid Johnson & JohnsonOtsuka

Issue brief |

19 October 2020

DR-TB and TB-Prevention Drugs Under the Microscope, 7th Edition

Medicine pricing and patent issues for drug-resistant tuberculosis and tuberculosis prevention

Tags Tuberculosis drug-resistant TBtuberculosis pretomanidbedaquilinedelamanid Union Conference on Lung HealthJohnson & JohnsonOtsuka DRTB Drugs Under the Microscope

Issue brief |

22 October 2019

DR-TB Drugs Under the Microscope, 6th Edition

Drug resistance is a major public health crisis thwarting the effective treatment and care of people living with tuberculosis (TB) – the world’s leading infectious disease killer. But with the release of new curative medicines and ...

Tags Tuberculosis drug-resistant TBtuberculosis pretomanidbedaquilinedelamanid Union Conference on Lung HealthJohnson & JohnsonOtsuka DRTB Drugs Under the Microscope

Close up of sachets of the drug Delamanid in the Town 2 Clinic, Kuyasa, Khayelitsha, Western Cape in South Africa.

Press release |

09 October 2019

MSF calls for new price of anti TB drug delamanid to be lowered and offered outside of South Africa

Tags Tuberculosis delamanid The Global Drug FacilityOtsuka South Africa

Issue brief |

18 September 2019

Making the Switch

Saving more lives with optimal treatment for drug-resistant TB

Tags Tuberculosis drug-resistant TBtuberculosis moxifloxacinlinezolidbedaquilinedelamanid access to medicinesdiagnostic testsgeneric medicinesinnovationresearch and development (R&D)voluntary licence Union Conference on Lung HealthTB AllianceJohnson & JohnsonOtsuka DRTB Drugs Under the Microscope

Issue brief |

22 October 2018

DR-TB Drugs Under the Microscope, 5th Edition

The 5th edition of “DR-TB Drugs Under the Microscope” chronicles the changing landscape of available treatments for DR-TB, outlines the key barriers to accessing the most effective treatments, and makes recommendations for action that ...